Clinical Trial Update: Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

View source ↗

Summary

A Europe-wide clinical trial compares surgical resection of the primary tumor versus systemic treatment alone for patients with small intestinal neuroendocrine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Intestinal Neuroendocrine Tumor

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Neuroendocrine (NE) Tumors, Metastasis | Status: RECRUITING